Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Germaine Gross has spent over 30 years in life sciences and 15 years leading CRO Business Development efforts.
January 16, 2025
By: Charlie Sternberg
Associate Editor, Contract Pharma
Emmes Group, a specialty tech and AI-enabled global contract research organization (CRO), has appointed Germaine Gross as Chief Commercial Officer of Emmes Biopharma.
With more than 30 years in life sciences and 15 years leading CRO Business Development efforts, Gross will spearhead the next phase of growth in Emmes Biopharma’s business portfolio. Reporting directly to Emmes Group Chief Executive Officer Sastry Chilukuri and serving on the company’s Executive Management Committee, she will play a critical role in deepening Emmes’ partnerships and delivering transformative solutions for biopharma-sponsored clinical trials.
“Germaine’s impressive track record of leadership, industry expertise, and proven ability to cultivate lasting partnerships makes her the perfect fit for this role,” said Sastry Chilukuri, Chief Executive Officer. “Her appointment comes at a pivotal moment as we redefine how biopharma clinical research is conducted by leveraging AI, advanced technology, and operational excellence. We’re confident that Germaine’s leadership will amplify our ability to deliver exceptional value to our biopharma partners.”
Gross has held leadership roles at industry-leading organizations such as ICON, PRA Health Sciences, and INC Research, where she successfully developed and expanded business portfolios. Prior to joining Emmes, she led the Asia Pacific Commercial Team at ICON.
With deep expertise in mergers and acquisitions, commercial operations, and strategic alliances, Gross has a proven ability to foster strong partnerships and implement innovative solutions. Her track record aligns seamlessly with Emmes Group’s vision for transformative growth.
Gross said: “Emmes has an extraordinary legacy of innovation and scientific excellence across its 47-year history. Combining this legacy with cutting-edge technology and AI to enable faster, higher quality clinical research has the potential to transform the industry. I look forward to working with the talented team at Emmes Group to expand our reach, enhance client partnerships, and help shape the future of biopharma clinical trials.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !